Illumina helps German hospital leadership accelerate…

04/25/2022 – 08:01 Illumina, Inc. San Diego, Oct. 1 /PRNewswire/ A study from Hannover Medical School will evaluate the use of whole genome sequencing to show positive effects of early diagnosis and treatment in children suspected of having genetic disorders. Illumina, Inc. announced. (NASDAQ:ILMN), the global leader in DNA sequencing and matrix-based technologies, today announced … Read more